News
Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...
1h
WISH-TV on MSNLilly to begin direct Zepbound shipmentsLilly will start shipping Zepbound to cash-paying customers, gas prices are rising, At Home has filed for bankruptcy, and ...
Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...
Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...
Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...
Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
Novo Nordisk (NYSE: NVO) stock had a Monday to forget, as news from a top rival dampened sentiment on the Danish ...
Eli Lilly is acquiring Verve Therapeutics to strengthen its cardiovascular pipeline with a gene-editing drug targeting PCSK9-linked conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results